REGN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 7.48%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $108,213,348.64

Regeneron Pharmaceuticals Insider Trading History Chart

Regeneron Pharmaceuticals Share Price & Price History

^$1,131.50

▼ -19.06 (-1.66%)

As of 09/6/2024 01:00 AM ET

Days: 30 | 90 | 365

What is Nvidia’s New $1 Trillion SuperProject?

From Weiss Ratings | Ad

Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …

Find out details on these three critical Nvidia partners immediately.

Regeneron Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/28/2024	Christopher R. Fenimore	CFO	Sell	5,680	$1,205.33	$6,846,274.40	15,305
8/7/2024	Jason Pitofsky	VP	Sell	487	$1,070.00	$521,090.00	4,204
7/11/2024	Joseph J. Larosa	EVP	Sell	1,866	$1,088.95	$2,031,980.70	37,937
7/1/2024	Arthur F. Ryan	Director	Sell	100	$1,059.24	$105,924.00	17,882
7/1/2024	Marion Mccourt	EVP	Sell	1,137	$1,047.11	$1,190,564.07	12,931
6/24/2024	Bonnie L. Bassler	Director	Sell	756	$1,062.00	$802,872.00	1,382
6/14/2024	Michael S. Brown	Director	Sell	1,535	$1,040.00	$1,596,400.00	1,382
6/11/2024	Leonard S. Schleifer	CEO	Sell	9,064	$1,015.43	$9,203,857.52	55,134
6/6/2024	Leonard S. Schleifer	CEO	Sell	787	$1,015.02	$798,820.74	64,198
6/5/2024	Bonnie L. Bassler	Director	Sell	827	$1,011.00	$836,097.00	1,382
5/28/2024	Michael S. Brown	Director	Sell	1,172	$974.86	$1,142,535.92	1,382
5/17/2024	Leonard S. Schleifer	CEO	Sell	22,830	$979.23	$22,355,820.90	466,877
5/14/2024	Leonard S. Schleifer	CEO	Sell	25,000	$979.25	$24,481,250.00	408,200
3/14/2024	Andrew J. Murphy	EVP	Sell	5,783	$956.47	$5,531,266.01	48,306
3/1/2024	Arthur F. Ryan	Director	Sell	100	$982.05	$98,205.00	18,282
3/1/2024	Marion Mccourt	EVP	Sell	358	$967.50	$346,365.00	13,431
2/26/2024	Bonnie L. Bassler	Director	Sell	854	$979.25	$836,279.50	1,382
2/22/2024	Joseph J. Larosa	EVP	Sell	1,000	$967.65	$967,650.00	37,543
2/7/2024	Joseph J. Larosa	EVP	Sell	1,000	$950.00	$950,000.00	38,543
2/5/2024	Marion Mccourt	EVP	Sell	1,000	$934.71	$934,710.00	13,789
2/1/2024	Arthur F. Ryan	Director	Sell	100	$954.22	$95,422.00	18,382
1/30/2024	Bonnie L. Bassler	Director	Sell	827	$959.00	$793,093.00	1,382
1/23/2024	Joseph L. Goldstein	Director	Sell	2,707	$950.00	$2,571,650.00	6,382
1/2/2024	George D. Yancopoulos	Insider	Sell	16,848	$900.00	$15,163,200.00	180,000
12/27/2023	Christopher R. Fenimore	SVP	Sell	2,448	$856.71	$2,097,226.08	14,372
12/27/2023	Michael S. Brown	Director	Sell	2,049	$898.00	$1,840,002.00	1,247
12/21/2023	Christopher R. Fenimore	SVP	Sell	1,680	$844.01	$1,417,936.80	17,070
12/1/2023	Arthur F. Ryan	Director	Sell	100	$817.30	$81,730.00	18,447
11/7/2023	Arthur F. Ryan	Director	Sell	100	$827.90	$82,790.00	18,547
11/1/2023	Marion Mccourt	EVP	Sell	1,000	$783.91	$783,910.00	19,803
10/13/2023	Huda Y. Zoghbi	Director	Sell	1,000	$850.00	$850,000.00	1,247
10/2/2023	Marion Mccourt	EVP	Sell	1,038	$827.00	$858,426.00	19,803
8/24/2023	Plew Daniel P Van	EVP	Sell	6,197	$841.71	$5,216,076.87	21,508
8/23/2023	Christine A. Poon	Director	Sell	12,280	$839.97	$10,314,831.60	2,037
8/23/2023	Robert E. Landry	CFO	Sell	223	$844.00	$188,212.00	31,699
8/22/2023	Neil Stahl	EVP	Sell	11,665	$840.98	$9,810,031.70	53,100
8/21/2023	Bonnie L. Bassler	Director	Sell	853	$829.00	$707,137.00	1,247
8/10/2023	Bonnie L. Bassler	Director	Sell	853	$789.00	$673,017.00	1,247
8/1/2023	Arthur F. Ryan	Director	Sell	100	$736.59	$73,659.00	18,647
7/3/2023	Arthur F. Ryan	Director	Sell	100	$716.88	$71,688.00	18,747
7/3/2023	Marion Mccourt	EVP	Sell	250	$710.09	$177,522.50	20,303
6/1/2023	Arthur F. Ryan	Director	Sell	100	$735.42	$73,542.00	18,847
6/1/2023	Marion Mccourt	EVP	Sell	250	$736.00	$184,000.00	20,553
4/21/2023	Michael S. Brown	Director	Sell	3,070	$798.42	$2,451,149.40	1,247
4/3/2023	Arthur F. Ryan	Director	Sell	100	$819.31	$81,931.00	19,047
4/3/2023	Marion Mccourt	EVP	Sell	1,100	$818.80	$900,680.00	20,803
3/27/2023	Robert E. Landry	CFO	Sell	183	$821.70	$150,371.10	32,929
3/24/2023	Bonnie L. Bassler	Director	Sell	1,240	$818.00	$1,014,320.00	1,247
3/23/2023	Christopher R. Fenimore	SVP	Sell	2,192	$806.47	$1,767,782.24	18,409
3/23/2023	George D. Yancopoulos	Insider	Sell	3,656	$804.26	$2,940,374.56	196,848
3/1/2023	Arthur F. Ryan	Director	Sell	100	$762.50	$76,250.00	19,147
3/1/2023	Marion Mccourt	EVP	Sell	1,100	$759.89	$835,879.00	20,803
2/7/2023	Marion Mccourt	EVP	Sell	1,000	$769.04	$769,040.00	22,079
2/6/2023	George D. Yancopoulos	Insider	Sell	13,189	$800.08	$10,552,255.12	200,504
2/6/2023	Joseph L. Goldstein	Director	Sell	3,613	$800.00	$2,890,400.00	6,247
2/6/2023	Robert E. Landry	CFO	Sell	752	$788.88	$593,237.76	32,105
2/3/2023	Bonnie L. Bassler	Director	Sell	1,021	$779.00	$795,359.00	1,247
2/3/2023	Robert E. Landry	CFO	Sell	739	$764.50	$564,965.50	32,105
1/27/2023	Michael S. Brown	Director	Sell	1	$747.00	$747.00	1,247
12/28/2022	N. Anthony Coles	Director	Sell	5,758	$714.11	$4,111,845.38	1,093
12/12/2022	Marion Mccourt	EVP	Sell	264	$730.17	$192,764.88	19,106
12/8/2022	Bonnie L. Bassler	Director	Sell	218	$779.00	$169,822.00	1,082
11/23/2022	Plew Daniel P Van	EVP	Sell	11,972	$740.75	$8,868,259.00	30,578
11/4/2022	Marion Mccourt	EVP	Sell	1,000	$727.82	$727,820.00	19,644
10/17/2022	Robert E. Landry	CFO	Sell	358	$739.50	$264,741.00	28,744
10/5/2022	Christopher R. Fenimore	SVP	Sell	1,844	$749.00	$1,381,156.00	16,425
10/3/2022	Christopher R. Fenimore	SVP	Sell	3,346	$724.00	$2,422,504.00	18,269
10/3/2022	Marc Tessier-Lavigne	Director	Sell	3,612	$718.00	$2,593,416.00	2,269
10/3/2022	Marion Mccourt	EVP	Sell	1,100	$705.39	$775,929.00	19,644
9/30/2022	Marc Tessier-Lavigne	Director	Sell	3,428	$698.00	$2,392,744.00	2,269
9/12/2022	Plew Daniel P Van	EVP	Sell	4,696	$716.38	$3,364,120.48	30,578
9/9/2022	Bonnie L. Bassler	Director	Sell	609	$741.00	$451,269.00	1,082
8/9/2022	Christine A. Poon	Director	Sell	15,000	$620.91	$9,313,650.00	1,872
8/5/2022	Neil Stahl	EVP	Sell	23,782	$612.61	$14,569,091.02	52,795
8/4/2022	Arthur F. Ryan	Director	Sell	10,453	$621.29	$6,494,344.37	18,408
8/1/2022	Marion Mccourt	EVP	Sell	1,100	$581.53	$639,683.00	19,644
7/1/2022	Marion Mccourt	EVP	Sell	1,100	$587.76	$646,536.00	19,644
5/2/2022	Arthur F. Ryan	Director	Sell	100	$650.78	$65,078.00	22,182
5/2/2022	Marion Mccourt	EVP	Sell	1,100	$656.97	$722,667.00	19,644
4/11/2022	Robert E. Landry	CFO	Sell	1,862	$734.06	$1,366,819.72	28,744
4/8/2022	Robert E. Landry	CFO	Sell	325	$737.79	$239,781.75	28,744
4/7/2022	Bonnie L. Bassler	Director	Sell	1,240	$725.00	$899,000.00	1,082
4/7/2022	Joseph J. Larosa	EVP	Sell	5,114	$721.10	$3,687,705.40	16,900
4/5/2022	Leonard S. Schleifer	CEO	Sell	4,461	$710.05	$3,167,533.05	465,922
4/1/2022	Arthur F. Ryan	Director	Sell	100	$692.81	$69,281.00	22,282
4/1/2022	Marion Mccourt	EVP	Sell	1,000	$701.82	$701,820.00	22,014
4/1/2022	Robert E. Landry	CFO	Sell	316	$695.81	$219,875.96
3/31/2022	Leonard S. Schleifer	CEO	Sell	2,886	$710.01	$2,049,088.86	465,922
3/30/2022	Michael S. Brown	Director	Sell	408	$699.00	$285,192.00
3/29/2022	Robert E. Landry	CFO	Sell	2,683	$687.90	$1,845,635.70
3/21/2022	Marc Tessier-Lavigne	Director	Sell	7,439	$690.00	$5,132,910.00
3/21/2022	Robert E. Landry	CFO	Sell	300	$693.00	$207,900.00
3/17/2022	Robert E. Landry	CFO	Sell	83	$686.00	$56,938.00
3/16/2022	Marc Tessier-Lavigne	Director	Sell	4,361	$675.00	$2,943,675.00
2/28/2022	George L. Sing	Director	Sell	2,000	$615.50	$1,231,000.00
2/25/2022	George L. Sing	Director	Sell	2,000	$621.00	$1,242,000.00
2/23/2022	Plew Daniel P Van	EVP	Sell	6,781	$613.99	$4,163,466.19
2/1/2022	Arthur F. Ryan	Director	Sell	100	$607.14	$60,714.00
2/1/2022	Marion Mccourt	EVP	Sell	1,000	$607.46	$607,460.00
12/13/2021	Marion Mccourt	EVP	Sell	344	$653.12	$224,673.28
12/13/2021	Robert E. Landry	CFO	Sell	116	$662.50	$76,850.00
12/10/2021	Andrew J. Murphy	EVP	Sell	7,122	$666.27	$4,745,174.94
12/10/2021	Robert E. Landry	CFO	Sell	781	$666.42	$520,474.02
12/9/2021	Marc Tessier-Lavigne	Director	Sell	3,784	$665.00	$2,516,360.00
12/1/2021	Arthur F. Ryan	Director	Sell	100	$637.53	$63,753.00
12/1/2021	Marion Mccourt	EVP	Sell	1,000	$639.13	$639,130.00
11/22/2021	George L. Sing	Director	Sell	2,000	$657.50	$1,315,000.00
11/18/2021	George L. Sing	Director	Sell	4,000	$650.00	$2,600,000.00
11/17/2021	Robert E. Landry	CFO	Sell	681	$645.08	$439,299.48
11/16/2021	Andrew J. Murphy	EVP	Sell	7,167	$647.17	$4,638,267.39
11/16/2021	George L. Sing	Director	Sell	6,000	$656.26	$3,937,560.00
10/1/2021	Arthur F. Ryan	Director	Sell	100	$569.49	$56,949.00
10/1/2021	Marion Mccourt	EVP	Sell	1,000	$576.75	$576,750.00
9/15/2021	N. Anthony Coles	Director	Sell	11,948	$658.98	$7,873,493.04	7,811
9/13/2021	Michael S. Brown	Director	Sell	9,704	$648.16	$6,289,744.64	6,328
9/10/2021	Joseph L. Goldstein	Director	Sell	2,479	$650.00	$1,611,350.00	8,370

What is Nvidia’s New $1 Trillion SuperProject?

From Weiss Ratings | Ad

Find out details on these three critical Nvidia partners immediately.

SEC Filings (Institutional Ownership Changes) for Regeneron Pharmaceuticals (NASDAQ:REGN)

83.31% of Regeneron Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Regeneron Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
9/5/2024	Sanctuary Advisors LLC	45,299	$47.61M	0.3%	N/A	0.041%
8/28/2024	Kestra Investment Management LLC	416	$0.44M	0.0%	N/A	0.000%
8/28/2024	Souders Financial Advisors	762	$0.80M	0.1%	N/A	0.001%
8/27/2024	Clearbridge Investments LLC	1,433	$1.51M	0.0%	N/A	0.001%
8/27/2024	New Wave Wealth Advisors LLC	366	$0.39M	0.2%	N/A	0.000%
8/27/2024	New Century Financial Group LLC	298	$0.31M	0.1%	N/A	0.000%
8/26/2024	Teachers Retirement System of The State of Kentucky	15,494	$16.29M	0.1%	-5.2%	0.014%
8/22/2024	Cetera Investment Advisers	7,946	$8.35M	0.0%	-18.5%	0.007%
8/22/2024	3Chopt Investment Partners LLC	538	$0.57M	0.2%	N/A	0.000%
8/21/2024	Heartland Bank & Trust Co	624	$0.66M	0.4%	-31.4%	0.001%
8/21/2024	Truist Financial Corp	40,221	$42.27M	0.1%	-3.9%	0.037%
8/19/2024	EP Wealth Advisors LLC	1,258	$1.32M	0.0%	-1.3%	0.001%
8/19/2024	Kimelman & Baird LLC	54	$57K	0.0%	N/A	0.000%
8/19/2024	B. Riley Wealth Advisors Inc.	1,086	$1.14M	0.0%	+8.0%	0.001%
8/16/2024	Ironwood Investment Management LLC	200	$0.21M	0.1%	N/A	0.000%
8/16/2024	Seaport Global Advisors LLC	839	$0.88M	3.2%	+64.2%	0.001%
8/16/2024	Granite FO LLC	850	$0.89M	0.6%	N/A	0.001%
8/16/2024	Northwestern Mutual Wealth Management Co.	3,821	$4.02M	0.0%	+16.3%	0.003%
8/16/2024	NewEdge Advisors LLC	4,368	$4.59M	0.0%	+6.3%	0.004%
8/16/2024	Magnolia Capital Advisors LLC	225	$0.24M	0.0%	N/A	0.000%
8/16/2024	Creative Planning	9,615	$10.11M	0.0%	+11.5%	0.009%
8/16/2024	Copperwynd Financial LLC	788	$0.85M	0.3%	+4.6%	0.001%
8/16/2024	Forefront Analytics LLC	328	$0.35M	0.2%	-4.7%	0.000%
8/16/2024	Aviso Wealth Management	1,645	$1.73M	1.0%	+28.1%	0.001%
8/16/2024	Sepio Capital LP	2,570	$2.70M	0.2%	-0.7%	0.002%
8/15/2024	Susquehanna Fundamental Investments LLC	23,286	$24.47M	0.6%	+1,719.2%	0.021%
8/15/2024	Scientech Research LLC	1,774	$1.87M	0.4%	-17.3%	0.002%
8/15/2024	Legal & General Group Plc	978,109	$1.03B	0.2%	+0.0%	0.888%
8/15/2024	Lighthouse Investment Partners LLC	12,536	$13.18M	0.5%	+141.6%	0.011%
8/15/2024	Mackenzie Financial Corp	57,964	$60.92M	0.1%	+3.7%	0.053%
8/15/2024	The Manufacturers Life Insurance Company	340,566	$357.95M	0.3%	+0.7%	0.309%
8/15/2024	MBB Public Markets I LLC	7,532	$7.92M	0.2%	+2,095.9%	0.007%
8/15/2024	Daymark Wealth Partners LLC	295	$0.31M	0.0%	-15.0%	0.000%
8/15/2024	DE Burlo Group Inc.	8,690	$9.13M	1.2%	+7.4%	0.008%
8/15/2024	Decatur Capital Management Inc.	2,674	$2.81M	1.4%	+2.6%	0.002%
8/15/2024	APG Asset Management N.V.	127,424	$124.96M	0.2%	-11.4%	0.116%
8/15/2024	APG Asset Management US Inc.	31,376	$33.17M	0.2%	+2.4%	0.028%
8/15/2024	AQR Capital Management LLC	189,291	$198.57M	0.3%	+3.7%	0.172%
8/15/2024	Armistice Capital LLC	12,064	$12.68M	0.2%	-47.5%	0.011%
8/15/2024	AXA S.A.	92,654	$97.38M	0.3%	-8.4%	0.084%
8/15/2024	AlTi Global Inc.	527	$0.55M	0.0%	-2.0%	0.000%
8/15/2024	Alpha DNA Investment Management LLC	349	$0.37M	0.1%	-42.4%	0.000%
8/15/2024	Caxton Associates LP	1,150	$1.21M	0.0%	N/A	0.001%
8/15/2024	Point72 Europe London LLP	935	$0.98M	0.1%	N/A	0.001%
8/15/2024	Toronto Dominion Bank	53,341	$56.06M	0.1%	-14.3%	0.048%
8/14/2024	Fred Alger Management LLC	11,123	$11.69M	0.1%	-76.8%	0.010%
8/14/2024	Zurich Insurance Group Ltd FI	92,350	$97.06M	0.8%	+74.4%	0.084%
8/14/2024	Point72 Asset Management L.P.	22,871	$24.04M	0.1%	N/A	0.021%
8/14/2024	Insigneo Advisory Services LLC	1,059	$1.13M	0.1%	+11.2%	0.001%
8/14/2024	BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp	20,674	$21.73M	0.1%	+61.1%	0.019%
8/14/2024	Marshall Wace LLP	58,873	$61.88M	0.1%	-70.6%	0.053%
8/14/2024	Tri Locum Partners LP	17,516	$18.41M	4.7%	+104.5%	0.016%
8/14/2024	Morse Asset Management Inc	4,764	$5.01M	1.2%	+3.9%	0.004%
8/14/2024	Xponance Inc.	15,501	$16.29M	0.2%	-0.2%	0.014%
8/14/2024	Bank of Montreal Can	185,291	$199.56M	0.1%	-19.1%	0.168%
8/14/2024	Lombard Odier Asset Management Europe Ltd	1,690	$1.78M	0.1%	N/A	0.002%
8/14/2024	Evergreen Capital Management LLC	3,695	$3.88M	0.1%	+1.5%	0.003%
8/14/2024	Public Sector Pension Investment Board	3,841	$4.04M	0.0%	+77.7%	0.003%
8/14/2024	Nippon Life Global Investors Americas Inc.	840	$0.88M	0.0%	-21.5%	0.001%
8/14/2024	DRW Securities LLC	229	$0.24M	0.0%	-72.0%	0.000%
8/14/2024	EverSource Wealth Advisors LLC	635	$0.69M	0.0%	+23.1%	0.001%
8/14/2024	Gabelli Funds LLC	1,893	$1.99M	0.0%	+1.8%	0.002%
8/14/2024	Itau Unibanco Holding S.A.	40	$42K	0.0%	N/A	0.000%
8/14/2024	Fidelis Capital Partners LLC	534	$0.57M	0.1%	+27.1%	0.000%
8/14/2024	Epoch Investment Partners Inc.	163,296	$171.63M	0.8%	+57.7%	0.148%
8/14/2024	1832 Asset Management L.P.	2,185	$2.30M	0.0%	-22.1%	0.002%
8/14/2024	Frank Rimerman Advisors LLC	577	$0.61M	0.0%	+19,133.3%	0.001%
8/14/2024	ProShare Advisors LLC	113,211	$118.99M	0.3%	-9.6%	0.103%
8/14/2024	Profund Advisors LLC	12,669	$13.32M	0.5%	+15.1%	0.011%
8/13/2024	Hancock Whitney Corp	7,805	$8.20M	0.3%	-0.9%	0.007%
8/13/2024	Kayne Anderson Rudnick Investment Management LLC	5,657	$5.95M	0.0%	+28.7%	0.005%
8/13/2024	Legacy Financial Advisors Inc.	878	$0.92M	0.2%	+8.5%	0.001%
8/13/2024	Ensign Peak Advisors Inc	128,711	$135.28M	0.2%	-3.4%	0.117%
8/13/2024	Westwood Holdings Group Inc.	12,301	$12.93M	0.1%	-1.6%	0.011%
8/13/2024	Summit Trail Advisors LLC	1,257	$1.32M	0.0%	+9.4%	0.001%
8/13/2024	Thrivent Financial for Lutherans	7,814	$8.21M	0.0%	-0.4%	0.007%
8/13/2024	Sei Investments Co.	24,944	$26.21M	0.0%	+2.2%	0.023%
8/13/2024	Pacer Advisors Inc.	16,464	$17.30M	0.0%	+9.5%	0.015%
8/13/2024	Skandinaviska Enskilda Banken AB publ	73,808	$77.58M	0.4%	-0.2%	0.067%
8/13/2024	AE Wealth Management LLC	547	$0.58M	0.0%	+19.4%	0.000%
8/13/2024	DCF Advisers LLC	10,400	$10.93M	5.6%	-1.9%	0.009%
8/13/2024	ASB Consultores LLC	576	$0.61M	0.2%	-28.0%	0.001%
8/13/2024	Simplify Asset Management Inc.	6,360	$6.69M	0.4%	+108.5%	0.006%
8/13/2024	Canada Pension Plan Investment Board	134,762	$141.64M	0.1%	+7.6%	0.122%
8/13/2024	Public Employees Retirement Association of Colorado	15,002	$15.77M	0.1%	-2.3%	0.014%
8/13/2024	Benjamin F. Edwards & Company Inc.	2,980	$3.13M	0.1%	+25.8%	0.003%
8/13/2024	Trust Investment Advisors	192	$0.20M	0.1%	N/A	0.000%
8/12/2024	Ieq Capital LLC	5,531	$5.81M	0.1%	+10.1%	0.005%
8/12/2024	Brighton Jones LLC	920	$0.97M	0.0%	+1.5%	0.001%
8/12/2024	Intech Investment Management LLC	15,143	$15.92M	0.2%	+17.4%	0.014%
8/12/2024	XTX Topco Ltd	1,057	$1.11M	0.1%	-69.1%	0.001%
8/12/2024	Mark Sheptoff Financial Planning LLC	135	$0.14M	0.1%	+35.0%	0.000%
8/12/2024	MRP Capital Investments LLC	291	$0.31M	0.3%	N/A	0.000%
8/12/2024	Kendall Capital Management	2,417	$2.54M	0.8%	-2.8%	0.002%
8/12/2024	Kentucky Retirement Systems	7,993	$8.40M	0.2%	-0.4%	0.007%
8/12/2024	Paces Ferry Wealth Advisors LLC	495	$0.52M	0.3%	-3.7%	0.000%
8/12/2024	Blair William & Co. IL	1,985	$2.09M	0.0%	-1.9%	0.002%
8/12/2024	Vanguard Personalized Indexing Management LLC	9,559	$10.05M	0.2%	+13.4%	0.009%
8/12/2024	Amalgamated Bank	21,438	$22.53M	0.2%	-1.4%	0.019%
8/12/2024	Meiji Yasuda Asset Management Co Ltd.	2,314	$2.43M	0.1%	+5.4%	0.002%

Data available starting January 2016

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascular glaucoma; and retinopathy of prematurity. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma; Praluent injection for heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in adults; REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused by Zaire ebolavirus; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer; and develops product candidates for treating patients with eye, allergic and inflammatory, cardiovascular and metabolic, infectious, and rare diseases; and cancer, pain, and hematologic conditions. It has collaboration with Mammoth Biosciences, Inc. to research, develop and commercialize in vivo CRISPR-based gene editing therapies for multiple tissues and cell types. The company was incorporated in 1988 and is headquartered in Tarrytown, New York.

Today's Range

Now: $1,131.50

$1,128.97

$1,152.87

50 Day Range

MA: $1,113.10

$1,024.09

$1,201.76

52 Week Range

Now: $1,131.50

$769.19

$1,211.20

Volume

616,625 shs

Average Volume

468,461 shs

Market Capitalization

$124.68 billion

P/E Ratio

33.43

Dividend Yield

N/A

Beta

0.12

Who are the company insiders with the largest holdings of Regeneron Pharmaceuticals?: Regeneron Pharmaceuticals' top insider investors include:
Leonard S Schleifer (CEO)
George Yancopoulos (Insider)
Neil Stahl (EVP)
Andrew J Murphy (EVP)
Joseph J Larosa (EVP)
Robert E Landry (CFO)
Plew Daniel P Van (EVP)
Marion Mccourt (EVP)
Arthur F Ryan (Director)
Christopher R Fenimore (SVP)
Christopher R Fenimore (CFO)
Joseph L Goldstein (Director)
Jason Pitofsky (VP)
Marc Tessier-Lavigne (Director)
Christine A Poon (Director)
Bonnie L Bassler (Director)
Michael S Brown (Director)
Huda Y Zoghbi (Director)
N Anthony Coles (Director)
Learn More about top insider investors at Regeneron Pharmaceuticals.
Who are the major institutional investors of Regeneron Pharmaceuticals?: Regeneron Pharmaceuticals' top institutional investors include:
Legal & General Group Plc — 0.89%
Bank of New York Mellon Corp — 0.78%
American Century Companies Inc. — 0.75%
Dimensional Fund Advisors LP — 0.53%
Massachusetts Financial Services Co. MA — 0.49%
BNP PARIBAS ASSET MANAGEMENT Holding S.A. — 0.45%
Learn More about top institutional investors of Regeneron Pharmaceuticals stock.
Which institutional investors are selling Regeneron Pharmaceuticals stock?: In the previous quarter, REGN stock was sold by these institutional investors:
Marshall Wace LLP
Assenagon Asset Management S.A.
American Century Companies Inc.
Bank of Montreal Can
Fred Alger Management LLC
Bank of New York Mellon Corp
Millennium Management LLC
State of New Jersey Common Pension Fund D
During the previous year, company insiders that have sold Regeneron Pharmaceuticals company stock include:
Leonard S Schleifer (CEO)
George Yancopoulos (Insider)
Neil Stahl (EVP)
Andrew J Murphy (EVP)
Joseph J Larosa (EVP)
Robert E Landry (CFO)
Plew Daniel P Van (EVP)
Marion Mccourt (EVP)
Arthur F Ryan (Director)
Christopher R Fenimore (SVP)
Christopher R Fenimore (CFO)
Joseph L Goldstein (Director)
Jason Pitofsky (VP)
Learn More investors selling Regeneron Pharmaceuticals stock.
Which institutional investors are buying Regeneron Pharmaceuticals stock?: During the last quarter, REGN stock was purchased by institutional investors including:
BNP PARIBAS ASSET MANAGEMENT Holding S.A.
TD Asset Management Inc
Zurcher Kantonalbank Zurich Cantonalbank
Massachusetts Financial Services Co. MA
Epoch Investment Partners Inc.
Sanctuary Advisors LLC
Zurich Insurance Group Ltd FI
Point72 Asset Management L.P.